MOLECULAR DEVICES CORP
SC 13G/A, 1997-02-13
LABORATORY ANALYTICAL INSTRUMENTS
Previous: MOLECULAR DEVICES CORP, SC 13G/A, 1997-02-13
Next: FINANCIAL ASSET SECURITIES CORP, 8-K, 1997-02-13



<PAGE>
                               UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

                                SCHEDULE 13G

        INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
                 UNDER THE SECURITIES EXCHANGE ACT OF 1934
                          (Amendment No. 1)*

                        Molecular Devices Corporation
                     ----------------------------------
                              (Name of Issuer)

                                   Common
                     ----------------------------------
                       (Title of Class of Securities)

                                 60851C107
                     ----------------------------------
                              (CUSIP Number)

   Check the  following box if a fee is being paid with this statement / /.  (A
fee is not required only if the filing person:  (1) has a previous statement on
file reporting  beneficial  ownership of more than five percent of the class of
securities  described in Item 1;  and (2)  has  filed no  amendment  subsequent
thereto reporting  beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

   *The remainder of  this cover  page  shall  be  filled  out  for a reporting
person's  initial  filing on this  form with  respect to the  subject  class of
securities,  and for any  subsequent  amendment  containing  information  which
would alter the disclosures provided in a prior page.

   The information  required in the  remainder of this  cover page shall not be
deemed to be "filed"  for the purpose of  Section 18 of the Securities Exchange
Act of 1934  ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other  provisions of the Act  (however, see
the Notes).




                              Page 1 of 5 Pages


<PAGE>

CUSIP No. 60851C107                   13G                 Page  2  of  5  Pages
          ---------                                            ---    --- 

- -------------------------------------------------------------------------------
 (1) Names of Reporting Persons.  S.S. or I.R.S. Identification Nos. of Above
     Persons

     Moshe Alafi
- -------------------------------------------------------------------------------
 (2) Check the Appropriate Box if a Member     (a)  / /
     of a Group*                               (b)  /X/
- -------------------------------------------------------------------------------
 (3) SEC Use Only

- -------------------------------------------------------------------------------
 (4) Citizenship or Place of Organization
     United States
- -------------------------------------------------------------------------------
Number of Shares              (5) Sole Voting
 Beneficially                       Power                  825
 Owned by                    --------------------------------------------------
 Each Reporting               (6) Shared Voting
 Person With                        Power                  722,468 
                             --------------------------------------------------
                              (7) Sole Dispositive
                                    Power                  825
                             --------------------------------------------------
                              (8) Shared Dispositive
                                    Power                  722,468 
- -------------------------------------------------------------------------------
 (9) Aggregate Amount Beneficially Owned by Each Reporting Person
     723,293
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
     X
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
     8.0%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
     IN
- -------------------------------------------------------------------------------
                    *SEE INSTRUCTION BEFORE FILLING OUT!

                              Page 2 of 5 Pages

<PAGE>


ITEM 1(A).  NAME OF ISSUER
            Molecular Devices Corporation
- -------------------------------------------------------------------------------


ITEM 1(B).  ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
            1311 Orleans Drive, Sunnyvale, CA
- -------------------------------------------------------------------------------


ITEM 2(A).  NAME OF PERSON(S) FILING
            Moshe Alafi
- -------------------------------------------------------------------------------


ITEM 2(B).  ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
            P.O. Box 7338, Berkeley, CA 94707
- -------------------------------------------------------------------------------


ITEM 2(C).  CITIZENSHIP
            United States
- -------------------------------------------------------------------------------


ITEM 2(D).  TITLE OF CLASS OF SECURITIES
            Common
- -------------------------------------------------------------------------------


ITEM 2(E).  CUSIP NUMBER
            60851C107
- -------------------------------------------------------------------------------


ITEM 3.  IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b),
         CHECK WHETHER THE PERSON FILING IS A

         Not applicable.


ITEM 4.  OWNERSHIP

    (a) Amount Beneficially Owned:
        723,293
    ---------------------------------------------------------------------------

    (b) Percent of Class:
        8.0%
    ---------------------------------------------------------------------------

    (c) Number of shares as to which such person has:

          (i) sole power to vote or to direct the vote
              825
              -----------------------------------------------------------------
         (ii) shared power to vote or to direct the vote
              722,468
              -----------------------------------------------------------------
        (iii) sole power to dispose or to direct the disposition of
              825
              -----------------------------------------------------------------
         (iv) shared power to dispose or to direct the disposition of
              722,468
              -----------------------------------------------------------------

*  Includes 402,840 shares beneficially owned by Alafi Capital Company, of 
which Mr. Alafi, a director of the Company, is the general partner and 
319,628 shares beneficially owned by trusts for the benefit of Mr. Alafi's 
children, of which Mr. Alafi is the trustee.

ITEM 5.  OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

         Not applicable.
- -------------------------------------------------------------------------------

                              Page 3 of 5 Pages

<PAGE>

ITEM 6.  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
         Not applicable.
- -------------------------------------------------------------------------------


ITEM 7.  IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
         THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
         Not applicable.
- -------------------------------------------------------------------------------


ITEM 8.  IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
         Not applicable.
- -------------------------------------------------------------------------------


ITEM 9.  NOTICE OF DISSOLUTION OF GROUP
         Not applicable.
- -------------------------------------------------------------------------------


ITEM 10. CERTIFICATION
         Not applicable.
- -------------------------------------------------------------------------------

                              Page 4 of 5 Pages

<PAGE>

                                  SIGNATURE

    After  reasonable  inquiry and to the  best of my  knowledge and  belief, I
certify that the  information set forth in this statement is true, complete and
correct.

                                       2/14/97
                                       ----------------------------------------
                                       Date

                                       /s/ Moshe Alafi
                                       ----------------------------------------
                                       Signature

                                       Moshe Alafi
                                       ----------------------------------------
                                       Name/Title

                              Page 5 of 5 Pages


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission